We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $189M
1-Year Est. Return 67.72%
This Fund
S&P 500
This Quarter Est. Return
-2.49%
1 Year Est. Return
+67.72%
3 Year Est. Return
+169.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$168M
AUM Growth
-$47.9M
Cap. Flow
-$34.3M
Cap. Flow %
-20.4%
Top 10 Hldgs %
60.49%
Holding
95
New
8
Increased
17
Reduced
13
Closed
10

Top Buys

Rank Stock Value
1
IOVA icon
Iovance Biotherapeutics
IOVA
+$5.12M
2
AGIO icon
Agios Pharmaceuticals
AGIO
+$2.13M
3
RLMD icon
Relmada Therapeutics
RLMD
+$2.08M
4
ARDX icon
Ardelyx
ARDX
+$1.37M
5
TGTX icon
TG Therapeutics
TGTX
+$1.34M

Top Sells

Rank Stock Value
1
CLMT icon
Calumet Specialty Products
CLMT
+$44M
2
CPRX
Catalyst Pharmaceutical
CPRX
+$1.64M
3
TECX
Tectonic Therapeutic
TECX
+$1.54M
4
TVTX icon
Travere Therapeutics
TVTX
+$1.36M
5
BHVN icon
Biohaven
BHVN
+$1.25M

Sector Composition

Rank Sector Weight
1 Healthcare 53.57%
2 Financials 19.49%
3 Communication Services 15.66%
4 Technology 1.31%
5 Energy 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BX icon
76
Blackstone
BX
$112B
$24.1K 0.01%
210
– –
TMO icon
77
Thermo Fisher Scientific
TMO
$220B
$22.1K 0.01%
45
– –
UNH icon
78
UnitedHealth
UNH
$358B
$15.4K 0.01%
57
– –
CRM icon
79
Salesforce
CRM
$165B
$14.4K 0.01%
77
– –
STWD icon
80
Starwood Property Trust
STWD
$6.05B
$6.89K ﹤0.01%
400
– –
KD icon
81
Kyndryl
KD
$3.04B
$5.62K ﹤0.01%
428
– –
GEHC icon
82
GE HealthCare
GEHC
$33.3B
$3.56K ﹤0.01%
50
– –
WAB icon
83
Wabtec
WAB
$50.3B
$1.5K ﹤0.01%
6
– –
BHVN icon
84
Biohaven
BHVN
$2.24B
– –
-110,720
Closed -$1.25M
CLMT icon
85
Calumet Specialty Products
CLMT
$4.29B
– –
-2,214,969
Closed -$44M
DAWN
86
DELISTED
Day One Biopharmaceuticals
DAWN
– –
-25,884
Closed -$241K
FATE icon
87
Fate Therapeutics
FATE
$294M
– –
-365,000
Closed -$359K
MRSN
88
DELISTED
Mersana Therapeutics
MRSN
– –
-111,686
Closed -$438K
NKTR icon
89
Nektar Therapeutics
NKTR
$2.57B
– –
-15,500
Closed -$655K
QURE icon
90
uniQure
QURE
$3.26B
– –
-4,000
Closed -$95.7K
SRRK icon
91
Scholar Rock
SRRK
$6.46B
– –
-13,913
Closed -$613K
XENE icon
92
Xenon Pharmaceuticals
XENE
$6.21B
– –
-10,962
Closed -$491K
TECX
93
Tectonic Therapeutic
TECX
$664M
– –
-74,000
Closed -$1.54M
1 2 3
4

Similar funds

SF
Steffes Financial Overland Park, Kansas $189M AUM
WDOM
Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return
BC
Beaconlight Capital New York $190M AUM 95.82% 1-Year Est. Return
CFA
Camarda Financial Advisors Fleming Island, Florida $190M AUM 48.71% 1-Year Est. Return
HCM
Harspring Capital Management New York $190M AUM 19.3% 1-Year Est. Return
RCAP
Resolute Capital Asset Partners Denver, Colorado $190M AUM 160.65% 1-Year Est. Return
AAA
American Alpha Advisors New York $188M AUM 42.65% 1-Year Est. Return
CCM
Clearfield Capital Management New York $188M AUM 84.86% 1-Year Est. Return

David M. Knott Jr's Q1 2026 Portfolio in Review

As of Q1 2026, David M. Knott Jr held 95 positions worth $168M, down 22% from $216M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

David M. Knott Jr withdrew a net $34.3M in Q1 2026, closing 10 positions and reducing 13 holdings. Its most notable exit was Calumet Specialty Products, an estimated $44M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, up from 41% a quarter earlier, followed by Financials and Communication Services.

Against the trend, David M. Knott Jr opened a new position in Iovance Biotherapeutics worth $5.62M.

  • David M. Knott Jr's largest Q1 2026 buy was Iovance Biotherapeutics: 1,600,000 shares worth $5.62M.
  • David M. Knott Jr added most to Agios Pharmaceuticals in Q1 2026, an estimated $2.13M increase.
  • David M. Knott Jr's biggest Q1 2026 reduction was Catalyst Pharmaceutical, cutting an estimated $1.64M.
  • David M. Knott Jr fully exited Calumet Specialty Products in Q1 2026, selling an estimated $44M.
  • David M. Knott Jr's ten largest holdings make up 60% of its $168M portfolio in Q1 2026.
  • David M. Knott Jr opened 8 new positions and closed 10 in Q1 2026.
  • David M. Knott Jr's portfolio value fell 22% quarter-over-quarter to $168M.

Based on David M. Knott Jr's 13F filing for Q1 2026, filed 14 May 2026.